Reference intervals and biological variation for kallikrein 6: Influence of age and renal failure

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 5, 2012, Pages 931-934

  Martínez Morillo, Eduardo ^a   Diamandis, Anastasia ^b   Diamandis, Eleftherios P ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biological variation; Kallikrein 6; Reference interval; Serum

Indexed keywords

CREATININE; KALLIKREIN 6;

ADULT; AGE; AGED; ARTICLE; AUTOMATION; BIOLOGICAL ACTIVITY; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; FEMALE; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; PLASMA; REFERENCE VALUES; RENAL INSUFFICIENCY; SERUM; YOUNG ADULT;

EID: 84866657318     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0075     Document Type: Article

References (20)

1. Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clin Biochem 2003;36:443-52.
2. Magklara A, Mellati AA, Wasney GA, Little SP, Sotiropoulou G, Becker GW, et al. Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem Biophys Res Commun 2003;307:948-55.
3. Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007;53:1423-32.
4. Bayani J, Diamandis EP. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6) [review]. Clin Chem Lab Med 2012;50:211-33.
5. Kim JT, Song EY, Chung KS, Kang MA, Kim JW, Kim SJ, et al. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer 2011;117:2608-19.
6. El Sherbini MA, Sallam MM, Shaban EA, El-Shalakany AH. Diagnostic value of serum kallikrein-related peptidases 6 and 10 versus CA125 in ovarian cancer. Int J Gynecol Cancer 2011;21:625-32.
7. White NM, Mathews M, Yousef GM, Prizada A, Fontaine D, Ghatage P, et al. Human kallikrein related peptidases 6 and 13 in combination with CA125 is a more sensitive test for ovarian cancer than CA125 alone. Cancer Biomark 2009;5:279-87.
8. Menendez-Gonzalez M, Castro-Santos P, Suarez A, Calatayud MT, Perez-Pinera P, Martinez M, et al. Value of measuring plas-matic levels of neurosin in the diagnosis of Alzheimer's disease. J Alzheimers Dis 2008;14:59-67.
9. Hebb AL, Bhan V, Wishart AD, Moore CS, Robertson GS. Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis. Curr Drug Discov Technol 2010;7:137-40.
10. Scarisbrick IA, Sabharwal P, Cruz H, Larsen N, Vandell AG, Blaber SI, et al. Dynamic role of kallikrein 6 in traumatic spinal cord injury. Eur J Neurosci 2006;24:1457-69.
11. Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, et al. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin Biochem 2000;33:369-75.
12. CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline, 3rd ed. CLSI document C28-A3c. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
13. Fraser CG. Biological variation: from principles to practice. Washington: AACC Press, 2001.
14. Fraser CG. Are "scientific statements" the scientific truth? Accessed 11 December, 2011. Available from: http://www.west-gard.com/guest23. htm.
15. Ricos C, Cava F, Garcia-Lario J V, Hernandez A, Iglesias N, Jimenez C V, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004;64:175-84.
16. Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004;42:758-64.
17. Mitsui S, Okui A, Uemura H, Mizuno T, Yamada T, Yamamura Y, et al. Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease. Ann N YAcad Sci 2002;977:216-23.
18. Harris EK. Effects of intra-and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974;20:1535-42.
19. Petersen PH, Fraser CG, Sandberg S, Goldschmidt H. The index of individuality is often a misinterpreted quantity characteristic. Clin Chem Lab Med 1999;37:655-61.
20. Iglesias N, Petersen PH, Ricos C. Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality. Clin Chem Lab Med 2005;43:441-8.